World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
14885
World Ranking
3124
National Ranking
76

Melvin Berger publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Melvin Berger sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 181 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Melvin Berger D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Melvin Berger sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Melvin Berger is a researcher affiliated with CSL (Switzerland) in Switzerland, with a focus primarily on Earth and Planetary Sciences. Their work spans several subfields, including Geophysics, Oceanography, Environmental Chemistry, Astronomy and Astrophysics, and Molecular Biology.

The scientist's main research topics cover a diverse range, emphasizing:

  • Seismic Waves and Analysis
  • Geophysics and Gravity Measurements
  • Methane Hydrates and Related Phenomena
  • Ionosphere and magnetosphere dynamics
  • Monoclonal and Polyclonal Antibodies Research
  • Glycosylation and Glycoproteins Research
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Melvin Berger has contributed to several scholarly articles in various scientific journals. Notable selected recent publications include:

  • Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health (2023), published in Science Advances
  • Attributes that influence testing decisions for sexually transmitted and blood-borne infections: A qualitative study among diverse people in Canada (2025), published in International Journal of STD & AIDS
  • Diagnostiquer un lupus, ce n'est pas une mince affaire ! (2021), published in La Revue de Médecine Interne
  • Data for EMSL Project 60530 from October 2022 (2022), published in OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)

The frequent coauthors with whom Melvin Berger collaborates include John Melchior, Heather Olson, John Cort, Kwame Attah, and Che Clendinen.

Publication venues where Melvin Berger's work appears most often are:

  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  • Journal of Biological Chemistry
  • Science Advances
  • International Journal of STD & AIDS
  • La Revue de Médecine Interne

Melvin Berger's expertise encompasses interdisciplinary elements linking geophysical phenomena with biological and chemical processes. This includes specialization in seismic wave analysis and environmental chemical interactions, as well as contributions to the understanding of monoclonal antibodies and lipoproteins related to health risks.

Best Publications

  • T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years

    R. Michael Blaese;Kenneth W. Culver;A. Dusty Miller;Charles S. Carter

  • Inflammatory cytokines in cystic fibrosis lungs.

    T L Bonfield;J R Panuska;M W Konstan;K A Hilliard

  • Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

    Michael W. Konstan;Kathleen A. Hilliard;Tonya M. Norvell;Melvin Berger

  • Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

    Jordan S. Orange;Elham M. Hossny;Catherine R. Weiler;Mark Ballow

  • Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis.

    T L Bonfield;M W Konstan;P Burfeind;J R Panuska

  • Current understanding of the inflammatory process in cystic fibrosis: onset and etiology.

    Michael W. Konstan;Melvin Berger

  • Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.

    Michael F. Tosi;Harriet Zakem;Melvin Berger

  • Altered respiratory epithelial cell cytokine production in cystic fibrosis.

    Tracey L. Bonfield;Michael W. Konstan;Melvin Berger

  • Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases.

    Hans D. Ochs;Sudhir Gupta;Peter Kiessling;Uwe Nicolay

  • The role of inflammation in the pathophysiology of CF lung disease.

    James F. Chmiel;Melvin Berger;Michael W. Konstan

  • Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase.

    Yael Levy;Michael S. Hershfield;Cristina Fernandez-Mejia;Stephen H. Polmar

  • Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis

    Melvin Berger;R. U. Sorensen;M. F. Tosi;Dorr Gellatly Dearborn

  • Subcutaneous immunoglobulin replacement in primary immunodeficiencies.

    Melvin Berger

  • Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home

    Uwe Nicolay;Peter Kiessling;Melvin Berger;Sudhir Gupta

  • Parthenolide Inhibits IκB Kinase, NF-κB Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice

    Aicha Saadane;Sophia Masters;Joseph DiDonato;Jingfeng Li

  • Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.

    S. Jolles;J. S. Orange;A. Gardulf;M. R. Stein

  • Chronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling

    David Nichols;James F Chmiel;Melvin Berger

  • Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency.

    Melvin Berger

  • Subcutaneous immunoglobulin: Opportunities and outlook

    S. Misbah;M. H. Sturzenegger;M. Borte;R. S. Shapiro

  • Immunoglobulin Replacement Therapy by Slow Subcutaneous Infusion

    MELVlN Berger;Thomas R. Cupps;Anthony S. Fauci

  • Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency ☆: A randomized double-blind trial

    Chaim M Roifman;Harry Schroeder;Melvin Berger;Ricardo Sorensen

  • Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

    M. W. Konstan;K. A. Milliard;T. M. Norvell;M. Berger

Frequent Co-Authors

Michael W. Konstan
Michael W. Konstan Case Western Reserve University
Mark Ballow
Mark Ballow University of South Florida
Stephen Jolles
Stephen Jolles University Hospital of Wales
Ricardo U. Sorensen
Ricardo U. Sorensen Louisiana State University
Jordan S. Orange
Jordan S. Orange University of Pennsylvania
Michael M. Frank
Michael M. Frank Duke University
Rebecca H. Buckley
Rebecca H. Buckley Duke University
Hans D. Ochs
Hans D. Ochs University of Washington
Cornelia L. Dekker
Cornelia L. Dekker Stanford University
Neal A. Halsey
Neal A. Halsey Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students begin with foundational nursing programs before specializing. For instance, choosing from the easiest absn programs to get into allows for a quicker transition into nursing, providing essential medical knowledge applicable to immunology fields.

For entry-level positions, the which lpn programs are easiest to get into can be a practical starting point. Licensed Practical Nurse (LPN) programs offer hands-on patient care experience—an asset in immunology research and clinical settings.

Advancing to a nurse practitioner role is another pathway worth considering. Programs listed among the easiest online nurse practitioner programs provide flexible options for those balancing work and study. These degrees enhance clinical skills and deepen understanding of immune-related diseases.

For specialized mental health roles, exploring the best pmhnp programs online ensures access to quality clinical placements. Psychiatric-Mental Health Nurse Practitioner programs often intersect with immunology, particularly in understanding neuroimmunology and psychosomatic conditions.

Best Scientists Citing Melvin Berger

Trending Scientists

Recently Published Articles